Components of the transforming growth factor-β family and the pathogenesis of human achilles tendon pathology-a genetic association study

Rheumatology

Volumn 49, Issue 11, 2010, Pages 2090-2097

  Posthumus, Michael ^a   Collins, Malcolm ^b,c   Cook, Jill ^d   Handley, Christopher J ^e   Ribbans, William J ^a   Smith, Roger K W ^f   Schwellnus, Martin P ^b   Raleigh, Stuart M ^a  

^a UNIVERSITY OF NORTHAMPTON   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d DEAKIN UNIVERSITY   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Bone morphogenic protein 14; Cartilage derived morphogenic protein 1; Gene; Growth differentiation factor 5; Tendinopathy; Tendon injury; Tendon rupture

Indexed keywords

GROWTH DIFFERENTIATION FACTOR 5; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

5' UNTRANSLATED REGION; ACHILLES TENDINITIS; ACHILLES TENDON PATHOLOGY; ACHILLES TENDON RUPTURE; ADULT; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; TENDON DISEASE;

ACHILLES TENDON; ADULT; ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GROWTH DIFFERENTIATION FACTOR 5; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SOUTH AFRICA; TENDINOPATHY; TRANSFORMING GROWTH FACTOR BETA; VICTORIA;

EID: 78649375679     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq072     Document Type: Article

References (38)

1. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med 2009;43: 409-16.
2. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 2004;43:131-42.
3. Mokone GG, Schwellnus MP, Noakes TD, Collins M. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006;16:19-26.
4. September AV, Cook J, Handley CJ, Van der ML, Schwellnus MP, Collins M. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br J Sports Med 2009; 43:357-65.
5. Mokone GG, Gajjar M, September AV et al. The Guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33:1016-21.
6. Raleigh SM, Van der ML, Ribbans WJ, Smith RK, Schwellnus MP, Collins M. Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. Br J Sports Med 2009; 43:514-20.
7. Collins M, Raleigh SM. Genetic risk factors for musculoskeletal soft tissue injuries. Med Sport Sci 2009; 54:136-49.
8. September AV, Mokone GG, Schwellnus MP, Collins M. Genetic risk factors for Achilles tendon injuries. Int Sports Med J 2006;7:201-15.
9. Hou Y, Mao Z, Wei X et al. The roles of TGF-beta1 gene transfer on collagen formation during Achilles tendon healing. Biochem Biophys Res Commun 2009;383: 235-9.
10. Rickert M, Wang H, Wieloch P et al. Adenovirus-mediated gene transfer of growth and differentiation factor-5 into tenocytes and the healing rat Achilles tendon. Connect Tissue Res 2005;46:175-83.
11. Bolt P, Clerk AN, Luu HH et al. BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Joint Surg Am 2007;89:1315-20.
12. Mackey AL, Heinemeier KM, Koskinen SO, Kjaer M. Dynamic adaptation of tendon and muscle connective tissue to mechanical loading. Connect Tissue Res 2008; 49:165-8.
13. Vishnoi M, Pandey SN, Modi DR, Kumar A, Mittal B. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008;69:360-7.
14. Yuan X, Liao Z, Liu Z et al. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 2009;27: 3370-8.
15. Sharma S, Raby BA, Hunninghake GM et al. Variants in TGFB1, dust mite exposure, and disease severity in children with asthma. Am J Respir Crit Care Med 2009; 179:356-62.
16. Li H, Romieu I, Wu H et al. Genetic polymorphisms in transforming growth factor beta-1 (TGFB1) and childhood asthma and atopy. Hum Genet 2007;121:529-38.
17. Shah R, Hurley CK, Posch PE. A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C>T). Hum Genet 2006;120:461-9.
18. Langdahl BL, Uitterlinden AG, Ralston SH et al. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 2008;42:969-81.
19. Koch W, Hoppmann P, Mueller JC, Schomig A, Kastrati A. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol 2006;26:1114-9.
20. Grainger DJ, Heathcote K, Chiano M et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8:93-7.
21. Eliasson P, Fahlgren A, Aspenberg P. Mechanical load and BMP signaling during tendon repair: a role for follistatin? Clin Orthop Relat Res 2008;466:1592-7.
22. Mikic B. Multiple effects of GDF-5 deficiency on skeletal tissues: implications for therapeutic bioengineering. Ann Biomed Eng 2004;32:466-76.
23. Szczaluba K, Hilbert K, Obersztyn E, Zabel B, Mazurczak T, Kozlowski K. Du Pan syndrome phenotype caused by heterozygous pathogenic mutations in CDMP1 gene. Am J Med Genet A 2005;138:379-83.
24. Schwabe GC, Turkmen S, Leschik G et al. Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1. Am J Med Genet A 2004;124A: 356-63.
25. Basit S, Naqvi SK, Wasif N, Ali G, Ansar M, Ahmad W. A novel insertion mutation in the cartilage-derived morphogenetic protein-1 (CDMP1) gene underlies Grebe-type chondrodysplasia in a consanguineous Pakistani family. BMC Med Genet 2008;9:102.
26. Wolfman NM, Hattersley G, Cox K et al. Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest 1997;100: 321-30.
27. Mikic B, Schalet BJ, Clark RT, Gaschen V, Hunziker EB. GDF-5 deficiency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 2001;19:365-71.
28. Chapman K, Takahashi A, Meulenbelt I et al. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 50 UTR of GDF5 with osteoarthritis susceptibility. Hum Mol Genet 2008;17: 1497-504.
29. Dai J, Shi D, Zhu P et al. Association of a single nucleotide polymorphism in growth differentiate factor 5 with congenital dysplasia of the hip: a case-control study. Arthritis Res Ther 2008;10:R126.
30. Vaes RB, Rivadeneira F, Kerkhof JM et al. Genetic variation in the GDF5 region is associated with osteoarthritis, height, hip axis length and fracture risk: the Rotterdam study. Ann Rheum Dis 2008;68:1754-60.
31. Miyamoto Y, Mabuchi A, Shi D et al. A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat Genet 2007;39: 529-33.
32. Southam L, Rodriguez-Lopez J, Wilkins JM et al. An SNP in the 50-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage. Hum Mol Genet 2007;16:2226-32.
33. Egli RJ, Southam L, Wilkins JM et al. Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum 2009;60: 2055-64.
34. Lahiri K, Nurnberger JI. A rapid non-enzymaticmethod for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
35. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50.
36. Chhabra A, Tsou D, Clark RT, Gaschen V, Hunziker EB, Mikic B. GDF-5 deficiency in mice delays Achilles tendon healing. J Orthop Res 2003;21:826-35.
37. Tian C, Gregersen PK, Seldin MF. Accounting for ancestry: population substructure and genomewide association studies. Hum Mol Genet 2008;17: R143-50.
38. Gibson WT. Genetic association studies for complex traits: relevance for the sports medicine practitioner. Br J Sports Med 2008;43:314-6.